Featured Archives - Page 19 of 20

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

May 7, 2025

THIS WEEK'S STORIES

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

May 8, 2025

Cleerly and Cardiac Care Alliance Partner to Bring AI-Powered Imaging to Value-Based Heart Care

May 6, 2025

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

May 7, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

MassBio Warns of Looming Crisis in U.S. Biotech Sector as Federal Cuts and Trade Barriers Mount

EmPRO Insurance Expands into Massachusetts with Boston Office, Strengthening Northeast Presence

Most Read

GSK and Lifetime Team Up to Raise Awareness of Meningitis Through New Original Movie

What’s a fair price for a drug that’s never developed?

QuantHealth Launches First Clinical AI Foundation Model for Life Sciences Industry

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

EDITOR PICKS

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

THIS WEEK'S STORIES

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

Cleerly and Cardiac Care Alliance Partner to Bring AI-Powered Imaging to Value-Based Heart Care

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

POPULAR CATEGORY

ABOUT US

FOLLOW US